arrow
D

Delphine Planas

universite paris cite
H指数:37
被引数:9,721

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1

温度依赖性复制和对人冠状病毒HKU1先天免疫的敏感性

2026-07-270
OAAI
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates

非人灵长类中无佐剂CD40靶向SARS-CoV-2疫苗的免疫原性和保护效力

2026-07-010
OA
Plasma GDF-15 levels are associated with HIV reservoir markers independently of inflammation in people with HIV on antiretroviral therapy

血浆GDF-15水平与接受抗逆转录病毒治疗的HIV感染者中的HIV储库标志物相关,且这种相关性独立于炎症因素。

2026-01-010
OA
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo

靶向ACE2的骆驼单域抗体可抑制SARS-CoV-2的绑定并具有体内保护作用

2025-11-210
OAAI
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024-03-1345
OAAI
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants

Β-变体重组加强疫苗引起包括Omicron变体在内的SARS-CoV-2的广泛交叉反应中和

HELIYON
IF3.6
2024-03-011
OAAI
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
2024-01-233
OA
Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1
2023-12-0120
OAAI
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis
2023-10-203
OAAI
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
MED
IF11.8
2023-10-018
OAAI
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Omicron亚变体BA.2.75.2,BA.4.6和BQ.1.1对中和抗体的抗性

2023-02-14105
OAAI
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

接受单克隆抗体的患者血清中和SARS-CoV-2 Omicron BA.2,BA.4和BA.5的纵向分析

2022-12-0145
OAAI
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
2022-09-0118
OAAI
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab

鼻咽癌SARS-CoV-2 rt-pcr阴性的肾移植受者SARS-CoV-2感染在利妥昔单抗治疗后严重复发

2022-08-0111
OAAI
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
2022-06-1539
OAAI